{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:10:13Z","timestamp":1792131013932,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ophtha.2019.04.042","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T14:36:25Z","timestamp":1557239785000},"page":"1385-1398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan"],"prefix":"10.1016","volume":"126","author":[{"given":"Hitoshi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Shikishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Chuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keika","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Goseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyo","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keika","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Goseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyo","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Shikishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Chuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sugasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujikado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Aomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shinmei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuki","family":"Fukusima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Senoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kiyosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Nakamagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanao","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2019.04.042_bib1","first-page":"93","article-title":"Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG) [in Japanese]","volume":"99","author":"Wakakura","year":"1995","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2019.04.042_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0404.1975.tb05774.x","article-title":"The epidemiology of optic neuritis in Finland","volume":"52","author":"Wikstr\u00f6m","year":"1975","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ophtha.2019.04.042_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-510X(98)00141-5","article-title":"Incidence of optic neuritis in Stockholm, Sweden 1990\u20131995: I. Age, sex, birth and ethnic-group related patterns","volume":"159","author":"Jin","year":"1998","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ophtha.2019.04.042_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2019.04.042_bib5","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A\u00a0serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2019.04.042_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuro-myelitis optica: a multicenter study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.ophtha.2019.04.042_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0b013e31823c9b6c","article-title":"Relationship between NMO antibody and MOG-ab in optic neuritis","volume":"32","author":"Kezuka","year":"2012","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody seropositive and AQP4 antibody seropositive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2019.04.042_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporine-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/01658107.2015.1072726","article-title":"Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis","volume":"39","author":"Matsuda","year":"2015","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10384-018-0561-1","article-title":"Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis","volume":"62","author":"Kezuka","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.03.001","article-title":"Anti-MOG-antibodies in adult patients with demyelinating disorders of the central nervous system","volume":"270","author":"Tanaka","year":"2014","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/1352458507076976","article-title":"Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions","volume":"13","author":"Tanaka","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2019.04.042_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e3181cec45c","article-title":"MRI criteria for MS in patients with clinically isolated syndromes","volume":"74","author":"Montalban","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2019.04.042_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","article-title":"MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study","volume":"6","author":"Swanton","year":"2007","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.04.042_bib17","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.042_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/brain\/awf087","article-title":"Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance","volume":"125","author":"Kupersmith","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2019.04.042_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-6420(99)00133-5","article-title":"Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy","volume":"107","author":"Johnson","year":"2000","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.042_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.04.042_bib23","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"14","key":"10.1016\/j.ophtha.2019.04.042_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1177\/1352458517734070","article-title":"A\u00a0population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2019.04.042_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1874364101812010247","article-title":"Clinical characteristics, treatment outcomes and predictive factors in optic neuritis","volume":"12","author":"Hansapinyo","year":"2018","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ophtha.2019.04.042_bib26","series-title":"Epidemiology of MS 2013. P8\u201311","year":"2013"},{"key":"10.1016\/j.ophtha.2019.04.042_bib27","first-page":"1903","article-title":"Epidemiology of multiple sclerosis and neuromyelitis optica","volume":"72","author":"Miyamoto","year":"2014","journal-title":"Jpn J Clin Med"},{"key":"10.1016\/j.ophtha.2019.04.042_bib28","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ophtha.2019.04.042_bib29","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.0000000000000636","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"83","author":"Kezuka","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.042_bib31","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1212\/NXI.0000000000000175","article-title":"Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology","volume":"2","author":"Di Pauli","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ophtha.2019.04.042_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0021-5155(98)00072-0","article-title":"Baseline features of idiopathic optic neuritis as determined by multicenter treatment trial in Japan","volume":"43","author":"Wakaura","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib34","first-page":"751","article-title":"National clinical investigation of anti-aquaporine-4 seropositive optic neuritis [in Japanese]","volume":"118","author":"Endo","year":"2014","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2019.04.042_bib35","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0161-6420(03)00477-9","article-title":"Optic neuritis: correlation of pain and magnetic resonance imaging","volume":"110","author":"Fazzone","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.04.042_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2377-10-45","article-title":"Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis","volume":"18","author":"Nakajima","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib37","first-page":"233","article-title":"Clinical approach to optic neuropathies","volume":"1","author":"Behbehani","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10384-018-0602-9","article-title":"Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders","volume":"62","author":"Mori","year":"2018","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.042_bib39","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.042_bib40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.1988.01060140207023","article-title":"The Optic Neuritis Treatment Trial","volume":"106","author":"Beck","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib41","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2019.04.042_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"Park","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2019.04.042_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"10.1016\/j.ophtha.2019.04.042_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2015.05.013","article-title":"Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis","volume":"355","author":"Mealy","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ophtha.2019.04.042_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2016.02.004","article-title":"Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica","volume":"293","author":"Akaishi","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2016.09.007","article-title":"Different etiologies and prognoses of optic neuritis in demyelinating diseases","volume":"299","author":"Akaishi","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ophtha.2019.04.042_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286418762083","article-title":"Defining distinct features of anti-MOG antibody associated central nervous system demyelination","volume":"11","author":"Weber","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ophtha.2019.04.042_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody\u2013positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.042_bib50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.ophtha.2019.04.042_bib51","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201930226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201930226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:24Z","timestamp":1758982044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164201930226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S016164201930226X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.042","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}